JPWO2019204583A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019204583A5
JPWO2019204583A5 JP2020556835A JP2020556835A JPWO2019204583A5 JP WO2019204583 A5 JPWO2019204583 A5 JP WO2019204583A5 JP 2020556835 A JP2020556835 A JP 2020556835A JP 2020556835 A JP2020556835 A JP 2020556835A JP WO2019204583 A5 JPWO2019204583 A5 JP WO2019204583A5
Authority
JP
Japan
Prior art keywords
dry powder
inhalable dry
itraconazole
powder according
inhalable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020556835A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021522161A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/028089 external-priority patent/WO2019204583A1/en
Publication of JP2021522161A publication Critical patent/JP2021522161A/ja
Publication of JPWO2019204583A5 publication Critical patent/JPWO2019204583A5/ja
Pending legal-status Critical Current

Links

JP2020556835A 2018-04-18 2019-04-18 イトラコナゾールを含む肺内投与のための抗真菌配合物 Pending JP2021522161A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862659479P 2018-04-18 2018-04-18
US62/659,479 2018-04-18
PCT/US2019/028089 WO2019204583A1 (en) 2018-04-18 2019-04-18 Antifungal formulations for pulmonary administration comprising itraconazole

Publications (2)

Publication Number Publication Date
JP2021522161A JP2021522161A (ja) 2021-08-30
JPWO2019204583A5 true JPWO2019204583A5 (ru) 2022-04-14

Family

ID=66429608

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020556835A Pending JP2021522161A (ja) 2018-04-18 2019-04-18 イトラコナゾールを含む肺内投与のための抗真菌配合物

Country Status (4)

Country Link
US (1) US20210145739A1 (ru)
EP (1) EP3781125A1 (ru)
JP (1) JP2021522161A (ru)
WO (1) WO2019204583A1 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202000030443A1 (it) * 2020-12-10 2022-06-10 Zambon Spa Polvere inalabile comprendente voriconazolo in forma cristallina
IT202000030437A1 (it) * 2020-12-10 2022-06-10 Zambon Spa Metodo per la realizzazione di una polvere inalabile comprendente voriconazolo
US11471475B1 (en) 2022-03-08 2022-10-18 Ralph P. Stone Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery
WO2024040175A1 (en) 2022-08-18 2024-02-22 Pulmatrix Operating Company, Inc. Methods for treating cancer using inhaled angiogenesis inhibitor
WO2024049982A2 (en) 2022-08-31 2024-03-07 Pulmatrix Operating Company, Inc. Methods of using itraconazole dry powders

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069819A (en) 1973-04-13 1978-01-24 Societa Farmaceutici S.P.A. Inhalation device
US4916134A (en) 1987-03-25 1990-04-10 Janssen Pharmacuetica N.V. 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]phenyl]triazolones
IT1228459B (it) 1989-02-23 1991-06-19 Phidea S R L Inalatore con svuotamento regolare e completo della capsula.
EP1343372A2 (en) * 2000-12-21 2003-09-17 Nektar Therapeutics Pulmonary delivery of polyene antifungal agents
US9061027B2 (en) * 2004-08-27 2015-06-23 Board Of Regents, The University Of Texas System Enhanced delivery of drug compositions to treat life threatening infections
EP2227085A4 (en) * 2007-12-06 2013-10-09 Berg Pharma Llc INGREDIBLE COMPOSITIONS WITH INCREASED BIOLOGICAL AVAILABILITY
AU2011320159B2 (en) * 2010-10-29 2016-12-22 Western University Of Health Sciences Ternary mixture formulations
WO2013130767A1 (en) * 2012-02-29 2013-09-06 Pulmatrix, Inc. Inhalable dry powders
EP3525759A1 (en) * 2016-10-14 2019-08-21 Pulmatrix Operating Company, Inc. Antifungal dry powders

Similar Documents

Publication Publication Date Title
JP2019534270A5 (ru)
Lin et al. Powder production and particle engineering for dry powder inhaler formulations
RU2013118453A (ru) Катионы одновалентных металлов сухих порошков для ингаляций
RU2766086C2 (ru) Противогрибковые сухие порошки
CN103841960B (zh) 用于吸入的方法和制剂
JP2013540123A5 (ru)
JP2023086774A (ja) 乾燥粉末配合および使用方法
JP7048642B2 (ja) 肺、鼻、舌下および/または咽頭への送達に適した、少なくとも1つの生物活性化合物をロードした多孔質シリカ粒子の製造方法
JP2016519160A (ja) 3つ以上の活性薬剤を呼吸性送達するための組成物、方法、及びシステム
JP2006514679A (ja) トロスピウム含有組成物
JP2021522161A (ja) イトラコナゾールを含む肺内投与のための抗真菌配合物
US20190167579A1 (en) Itraconazole dry powders
JP6850524B2 (ja) 吸入用の乾燥粉末製剤
JPWO2019204583A5 (ru)
US20210113461A1 (en) Methods of Treating Fungal Infections
JP2023521396A (ja) ペラミビル乾燥粉末吸入剤及びその調製方法
CA3085943A1 (en) Surfactant formulations for inhalation
JP2024501372A (ja) 吸入用医薬組成物
RU2820457C2 (ru) Способы лечения грибковых инфекций
JPWO2020074894A5 (ru)
KR102259824B1 (ko) 보센탄을 함유한 약학 제제
WO2022122012A1 (zh) 用于肺部递送的药物组合物
Moon et al. and Robert O. Williams III1
Moon et al. Thin-Film Freeze-Drying Process for Versatile Particles for Inhalation Drug Delivery
Dongare et al. An Overview of Recently Published Patents on Pulmonary Drug Delivery Devices